White Paper: Meeting the challenge of synthesizing complex therapeutic peptides

The power and promise of therapeutic peptides

Peptides have high activity, great chemical and biological diversity, and low toxicity making them attractive targets for development of therapies. They are also easier and cheaper to produce than protein-based drugs and as a result, therapeutic peptides are being used to treat a range of conditions, including metabolic diseases, cancer, cardiovascular and infectious diseases, pain and hematology. One of the most exciting breakthroughs in oncology has been the development of neoantigen vaccines that have shown great promise in the treatment of cancers such as melanoma. Even more recently, the role of peptides is being investigated as a vaccine and immunotherapy for COVID-19.

Fill in the form to download the White Paper